Issue 4/2025
Hinkova G., Konakchieva M., Katsarov A., Katsarov K.
Clinic of Gastroenterology and Hepatology, Military Medical Academy – Sofia
MASLD is defined as the accumulation of triglycerides in the liver (in more than 5% of the parenchyma) in the presence of at least one cardiometabolic risk factor and in the absence of harmful alcohol intake. MASLD is the most common chronic liver disease and its incidence will increase over time. The spectrum of MASLD includes hepatic steatosis, MASH – steatohepatitis associated with metabolic dysfunction, liver fibrosis and cirrhosis, as well as MASH-associated hepatocellular carcinoma. The disease requires a multidisciplinary approach and collaboration between gastroenterologists, cardiologists, endocrinologists, and dietitians to ensure optimal treatment and reduce the risk of complications.
Key words: MASLD, metabolic syndrome, hepatic steatosis
Address for correspondence:
Hinkova G., Clinic of Gastroenterology and
Hepatology, Military Medical Academy – Sofia
ул. „св. Георги Софийски“ 3,
1606 София